财报披露
Scinai(SCNI)04-26 04:15
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036188 Act: 34 Size: 40 MB 网页链接
简介：Scinai Immunotherapeutics Ltd.于2003年7月22日在以色列成立,是一家私营公司。该公司是一家生物制药公司，专注于开发、制造和商业化创新的炎症和免疫学（I & I）生物产品，主要用于治疗自身免疫和传染病。Scinai拥有先进的生物制药产品开发和制造设施以及经验丰富的制药行业领导地位，提供端到端的精品CDMO服务，同时针对有大量未满足医疗需求的疾病，开发自己的多样化和商业上可行的产品和平台管道。
| 今开：3.75 | 昨收：3.92 |
| 最高：3.9999 | 最低：3.5201 |
| 涨停价： | 跌停价： |
| 总市值：1671451 |
Scinai(SCNI)04-26 04:15
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036188 Act: 34 Size: 40 MB 网页链接
Scinai(SCNI)05-16 04:15
$Scinai(SCNI)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-24-043560 Act: 34 Size: 6 MB 网页链接
Scinai(SCNI)06-13 22:25
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052281 Act: 34 Size: 34 KB 网页链接
Scinai(SCNI)06-13 22:25
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052278 Act: 34 Size: 24 KB 网页链接
Scinai(SCNI)06-14 19:35
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052622 Act: 34 Size: 15 MB 网页链接
Scinai(SCNI)04-17 05:35
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-033533 Act: 34 Size: 16 MB 网页链接
Scinai(SCNI)05-01 04:15
$Scinai(SCNI)$ NT 20-F Notification of inability to timely file Form 20-F Accession Number: 0001213900-24-037828 Act: 34 Size: 42 KB 网页链接
Scinai(SCNI)05-16 05:15
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-043778 Act: 34 Size: 30 KB 网页链接
Scinai(SCNI)05-07 22:25
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040299 Act: 34 Size: 24 KB 网页链接
Scinai(SCNI)05-29 02:15
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046981 Act: 34 Size: 25 KB 网页链接
F1watch2023-10-31 05:20
F-1 - Scinai Immunotherapeutics Ltd. (0001611747) (Filer) Filed: 2023-10-30 AccNo: 0001213900-23-081572 Size: 781 KB 网页链接查看全文
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052622 Act: 34 Size: 15 MB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052278 Act: 34 Size: 24 KB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-052281 Act: 34 Size: 34 KB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046981 Act: 34 Size: 25 KB 网页链接
$Scinai(SCNI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001019155-24-000135 Act: 33 Size: 78 KB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-043778 Act: 34 Size: 30 KB 网页链接
$Scinai(SCNI)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-24-043560 Act: 34 Size: 6 MB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040299 Act: 34 Size: 24 KB 网页链接
$Scinai(SCNI)$ NT 20-F Notification of inability to timely file Form 20-F Accession Number: 0001213900-24-037828 Act: 34 Size: 42 KB 网页链接
$Scinai(SCNI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036188 Act: 34 Size: 40 MB 网页链接